medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 5, 2024
Abstract
Noradrenaline
is
a
powerful
modulator
of
cognitive
processes,
including
action-decisions
underlying
saccadic
control.
Changes
in
eye
movements
are
common
across
neurodegenerative
diseases
ageing,
Parkinson’s
disease.
With
growing
interest
noradrenergic
treatment
potential
for
non-motor
symptoms
disease,
the
temporal
precision
oculomotor
function
advantageous
to
assess
effects
this
modulation.
Here
we
studied
effect
40
mg
atomoxetine,
noradrenaline
reuptake
inhibitor,
nineteen
people
with
idiopathic
disease
using
single
dose,
randomised
double-blind
crossover
placebo-controlled
design.
Twenty-five
healthy
adult
participants
completed
assessments
provide
normative
data.
Participants
performed
prosaccade
and
antisaccade
tasks.
The
latency,
velocity
accuracy
saccades,
resting
pupil
diameter,
were
measured.
Increased
diameter
on
drug
confirmed
its
expected
locus
coeruleus
ascending
arousal
system.
Atomoxetine
improved
key
aspects
saccade
performance:
latencies
faster
main
sequence
was
normalised.
These
improvements
accompanied
by
increased
error
rates
drug.
Together
these
findings
suggest
shift
speed-accuracy
trade-off
visuo-motor
decisions
response
treatment.
Our
results
new
evidence
substantiate
role
modulation
based
known
circuitry
advance
hypothesis
that
reflects
at
level
coeruleus–superior
colliculus
pathway.
Given
related
conditions,
system
can
support
assessment
without
limb-motor
confounds
task
performance.
Aging,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 29, 2025
Cellular
senescence
is
a
hallmark
of
aging
and
the
age-related
condition,
Alzheimer's
disease
(AD).
How
contributes
to
cholinergic
neuropathologic
changes
in
AD
remains
uncertain.
Furthermore,
little
known
about
relationship
between
cholinesterases
(ChEs).
Acetylcholinesterase
(AChE)
butyrylcholinesterase
(BChE)
are
important
neurotransmission,
cell
cycle
regulation,
amyloid-β
(Aβ)
pathology.
Senolytic
agents
have
shown
therapeutic
promise
models.
Therefore,
we
evaluated
vitro
silico
activity
senolytics,
dasatinib
(1),
nintedanib
(2),
fisetin
(3),
quercetin
(4),
GW2580
(5),
nootropic,
meclofenoxate
hydrochloride
(6),
toward
AChE
BChE.
As
ChEs
associated
with
pathology
altered
biochemical
properties,
also
1-6
brain
tissues.
Enzyme
kinetics
showed
1,
3,
4,
6
inhibited
both
ChEs,
while
2
5
only
AChE.
Histochemistry
inhibition
Aβ
plaque-associated
(1
2:
ChEs;
5:
BChE;
6:
AChE),
but
not
normal
neural-associated
ChEs.
Modeling
studies
interacted
same
five
binding
locations
some
which
may
be
allosteric
sites.
These
exert
their
beneficial
effects,
part,
by
inhibiting
provide
new
avenues
for
development
next-generation
inhibitors
targeting
pathology-associated
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3210 - 3210
Published: March 30, 2025
The
α7
nicotinic
acetylcholine
receptor
(α7-nAChR)
is
a
pivotal
regulator
of
neurotransmission,
neuroprotection,
and
immune
modulation
in
the
central
nervous
system.
This
review
explores
its
structural
functional
attributes,
highlighting
therapeutic
potential
neurodegenerative
disorders,
particularly
Parkinson’s
disease
(PD).
α7-nAChRs
mediate
synaptic
plasticity,
modulate
inflammatory
responses,
influence
dopamine
release,
positioning
them
as
promising
pharmacological
target.
Positive
allosteric
modulators
(PAMs)
enhance
α7-nAChR
activity
mainly
by
reducing
desensitization,
offering
superior
approach
compared
with
direct
agonists.
Emerging
preclinical
studies
suggest
that
activation
mitigates
dopaminergic
neurodegeneration,
improves
L-dopa-induced
dyskinesia,
reduces
neuroinflammation.
Despite
findings,
clinical
trials
have
yielded
mixed
results,
necessitating
further
research
into
optimizing
α7-targeted
therapies.
underscores
significance
PD
pathophysiology
highlights
future
directions
for
their
translational
neuroprotection
symptomatic
relief.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(8), P. 1672 - 1672
Published: April 8, 2025
Parkinson’s
disease
(PD)
is
a
complex
neurodegenerative
disorder
with
debilitating
non-motor
symptoms,
including
gastrointestinal
dysfunction,
cardiovascular
abnormalities,
mood
and
anxiety
disorders,
cognitive
decline,
sleep
disturbances,
respiratory
pain.
Despite
their
significant
impact
on
quality
of
life,
these
symptoms
are
often
inadequately
addressed.
Propolis
natural
bee-derived
product,
rich
in
bioactive
compounds
anti-inflammatory,
antioxidant,
immunomodulatory,
neuroprotective
properties,
which
holds
potential
PD
due
to
its
multitarget
multipathway
actions,
addressing
various
underlying
mechanisms
symptom
diseases.
Preclinical
clinical
studies
suggest
that
propolis
may
influence
key
pathological
PD’s
symptoms.
Evidence
points
benefits
improving
cognition,
health,
alleviating
sleep-related
issues.
Although
research
remains
scarce,
findings
from
related
conditions
ability
associated
This
review
underscores
the
underexplored
therapeutic
PD,
drawing
existing
evidence
advocating
for
further
fully
assess
role
patient
outcomes.
Communications Biology,
Journal Year:
2024,
Volume and Issue:
7(1)
Published: June 5, 2024
Abstract
Advanced
methods
such
as
REACT
have
allowed
the
integration
of
fMRI
with
brain’s
receptor
landscape,
providing
novel
insights
transcending
multiscale
organisation
brain.
Similarly,
normative
modelling
has
translational
neuroscience
to
move
beyond
group-average
differences
and
characterise
deviations
from
health
at
an
individual
level.
Here,
we
bring
these
together
for
first
time.
We
used
create
functional
networks
enriched
main
modulatory,
inhibitory,
excitatory
neurotransmitter
systems
generated
models
capture
connectivity
in
patients
schizophrenia,
bipolar
disorder
(BPD),
ADHD.
Substantial
overlap
was
seen
symptomatology
normality
across
groups,
but
could
be
mapped
into
a
common
space
linking
constellations
symptoms
through
underlying
neurobiology
transdiagnostically.
This
work
provides
impetus
developing
biomarkers
that
molecular-
systems-level
dysfunction
level,
facilitating
transition
towards
mechanistically
targeted
treatments.
Alzheimer s Research & Therapy,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: May 31, 2024
Autopsy
work
reported
that
neuronal
density
in
the
locus
coeruleus
(LC)
provides
neural
reserve
against
cognitive
decline
dementia.
Recent
neuroimaging
and
pharmacological
studies
left
frontoparietal
network
functional
connectivity
(LFPN-FC)
confers
resilience
beta-amyloid
(Aβ)-related
preclinical
sporadic
autosomal
dominant
Alzheimer's
disease
(AD),
as
well
LC-related
changes.
Given
LFPN
LC
play
important
roles
attention,
attention
deficits
have
been
observed
early
process,
we
examined
whether
LFPN-FC
structural
health
attenuate
attentional
context
of
AD
pathology.
142
participants
from
Harvard
Aging
Brain
Study
who
underwent
resting-state
MRI,
imaging,
PiB(Aβ)-PET,
up
to
5
years
follow-ups
were
included
(mean
age
=
74.5
±
9.9
years,
89
women).
Cross-sectional
robust
linear
regression
associated
integrity
(measured
average
five
continuous
voxels
with
highest
intensities
images)
or
Digit
Symbol
Substitution
Test
(DSST)
performance
at
baseline.
Longitudinal
mixed
effect
analyses
associations
between
DSST
(i)
two-way
interactions
baseline
(or
LFPN-FC)
PiB
(ii)
three-way
interaction
integrity,
LFPN-FC,
PiB.
Baseline
age,
sex,
education
covariates.
At
baseline,
lower
but
not
was
related
worse
performance.
Longitudinally,
a
faster
decline,
especially
>
10.38
CL.
Lower
steeper
on
independent
elevated
levels
(>
46
CL),
higher
an
attenuated
DSST,
despite
presence
integrity.
Our
findings
demonstrate
can
provide
Aβ-related
decline.
However,
when
Aβ
accumulates
LC's
resources
may
be
depleted,
functioning
cortical
target
regions
LC,
such
additional
sustain
AD.
These
results
critical
insights
into
correlates
contributing
individual
variability
risk
versus
Brain Communications,
Journal Year:
2024,
Volume and Issue:
6(5)
Published: Jan. 1, 2024
Noradrenaline
is
a
powerful
modulator
of
cognitive
processes,
including
action
decisions
underlying
saccadic
control.
Changes
in
eye
movements
are
common
across
neurodegenerative
diseases
ageing,
Parkinson's
disease.
With
growing
interest
noradrenergic
treatment
potential
for
non-motor
symptoms
disease,
the
temporal
precision
oculomotor
function
advantageous
to
assess
effects
this
modulation.
Here,
we
studied
effect
40
mg
atomoxetine,
noradrenaline
reuptake
inhibitor,
19
people
with
idiopathic
disease
using
single
dose,
randomized
double-blind,
crossover,
placebo-controlled
design.
Twenty-five
healthy
adult
participants
completed
assessments
provide
normative
data.
Participants
performed
prosaccade
and
antisaccade
tasks.
The
latency,
velocity
accuracy
saccades,
resting
pupil
diameter,
were
measured.
Increased
diameter
on
drug
confirmed
its
expected
locus
coeruleus
ascending
arousal
system.
Atomoxetine
altered
key
aspects
saccade
performance:
latencies
faster
main
sequence
was
normalized.
These
changes
accompanied
by
increased
error
rates
drug.
Together,
these
findings
suggest
shift
speed-accuracy
trade-off
visuomotor
response
treatment.
Our
results
new
evidence
substantiate
role
modulation
based
known
circuitry,
advance
hypothesis
that
reflects
at
level
coeruleus-superior
colliculus
pathway.
Given
related
conditions,
system
can
support
assessment
without
limb-motor
confounds
task
performance.
Neurobiology of Aging,
Journal Year:
2023,
Volume and Issue:
129, P. 195 - 208
Published: June 6, 2023
Maintaining
good
cognitive
function
is
crucial
for
well-being
across
the
lifespan.
We
proposed
that
degree
of
maintenance
determined
by
functional
interactions
within
and
between
large-scale
brain
networks.
Such
connectivity
can
be
represented
white
matter
architecture
structural
networks
shape
intrinsic
neuronal
activity
into
integrated
distributed
explored
how
function-structure
convergence,
divergence
from
connectivity,
contribute
to
adult
Multivariate
analyses
were
used
investigate
relationship
convergence
with
multivariate
profiles,
respectively.
Cognitive
was
increasingly
dependent
on
as
age
increased.
The
dependency
particularly
strong
high-order
cortical
subcortical
results
suggest
network
integrity
sustains
functions
in
old
age,
a
brain's
connectivity.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 8, 2024
Abstract
Noradrenaline
plays
an
integral
role
in
learning,
by
optimising
behavioural
strategies
and
facilitating
choice
execution.
Testing
the
noradrenergic
framework
of
learning
context
human
diseases
offers
a
test
bed
for
current
normative
neuroscience
theories
may
also
indicate
therapeutic
potential.
Parkinson's
disease
is
often
considered
as
model
dopamine
deficits,
including
dopamine’s
reinforcement
learning.
However,
function
severely
impaired
disease,
contributing
to
cognitive
deficits.
Using
single
dose
noradrenaline
reuptake
inhibitor
atomoxetine,
people
with
(n=19,
randomised
double-blind
placebo-controlled
crossover
design),
we
show
improvements
compared
placebo.
Computational
modelling
confirmed
substantial
shift
decision
noise
parameter,
indicative
more
exploitative
choices.
This
response
pattern
closely
resembled
that
age-matched
controls
(n=26)
simulations
optimal
strategies.
Pupillometry
revealed
increased
baseline
pupil
diameter
under
which
correlated
improvements,
heightened
phasic
pupillary
feedback.
Our
findings
confirm
contribution
doing
so
they
challenge
simple
interpretation
tonic-phasic
locus
coeruleus
firing
patterns
based
on
pupillometry.
Noradrenergic
modulation
potential
treatment
strategy
symptoms
related
disorders.
Molecular Psychiatry,
Journal Year:
2023,
Volume and Issue:
29(2), P. 402 - 411
Published: Dec. 5, 2023
Sleep
spindles
are
a
hallmark
of
non-REM
sleep
and
play
fundamental
role
in
memory
consolidation.
Alterations
these
emerging
as
sensitive
biomarkers
for
neurodegenerative
diseases
ageing.
Understanding
the
clinical
presentations
associated
with
spindle
alterations
may
help
to
elucidate
functional
distinct
electroencephalographic
oscillations
pathophysiology
disorders.
Here,
we
use
data-driven
approach
examine
sleep,
default
mode
network
connectivity
phenotypes
architecture
older
adults
(mean
age
=
66
years).
Participants
were
recruited
from
specialist
clinic
early
diagnosis
intervention
cognitive
decline,
proportion
showing
mild
deficits
on
neuropsychological
testing.
In
sample
88
people
who
underwent
assessment,
overnight
polysomnography
resting-state
fMRI,
k-means
cluster
analysis
was
applied
measures
interest:
fast
density,
duration
amplitude.
This
resulted
three
clusters,
characterised
by
preserved
higher
density
longer
(Cluster
1),
(Clusters
2
3).
These
clusters
further
reduced
3)
nocturnal
hypoxemia,
apnea
Resting-state
fMRI
confirmed
that
related
architecture,
although
directionality
this
relationship
differed
across
groups.
Together,
results
confirm
diversity
adults,
clinically
meaningful
phenotypes,
including
function
apnea.
They
suggest
during
awake
state
can
be
architecture;
however,
is
highly
dependent
phenotype.
Establishing
relationships
between
neuroimaging
features
will
advance
our
understanding
bidirectional
changes